Filing Details

Accession Number:
0000935836-25-000416
Form Type:
4
Zero Holdings:
No
Publication Time:
2025-06-05 18:51:15
Reporting Period:
2025-06-03
Filing Date:
2025-06-05
Accepted Time:
2025-06-05 18:51:15
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1799191 Oncology Institute Inc. TOI Services-Offices & Clinics Of Doctors Of Medicine (8011) 843562323
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1891124 Brad Hively C/O The Oncology Institute Inc.
18000 Studebaker Road, Suite 800
Cerritos CA 90703
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2025-06-03 684,528 $0.85 1,396,561 No 4 M Direct
Common Stock Acquisiton 2025-06-03 105,320 $0.48 1,501,881 No 4 M Direct
Common Stock Acquisiton 2025-06-03 131,297 $1.87 1,633,178 No 4 M Direct
Common Stock Acquisiton 2025-06-03 946,460 $0.85 2,579,638 No 4 M Direct
Common Stock Disposition 2025-06-03 1,867,605 $2.87 712,033 No 4 S Direct
Common Stock Disposition 2025-06-03 108,532 $2.87 603,501 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Non-Qualified Stock Option (right to buy) Acquisiton 2025-06-03 684,528 $0.00 684,528 $0.85
Common Stock Non-Qualified Stock Option (right to buy) Acquisiton 2025-06-03 105,320 $0.00 105,320 $0.48
Common Stock Non-Qualified Stock Option (right to buy) Acquisiton 2025-06-03 131,297 $0.00 131,297 $1.87
Common Stock Non-Qualified Stock Option (right to buy) Acquisiton 2025-06-03 946,460 $0.00 946,460 $0.85
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2029-12-02 No 4 M Direct
0 2033-03-17 No 4 M Direct
0 2032-11-17 No 4 M Direct
0 2029-12-02 No 4 M Direct
Footnotes
  1. Represents sale of Common Stock acquired from previously vested RSU awards.
  2. These options vested monthly for 36 months following November 12, 2021.
  3. These options vested monthly starting March 17, 2023, with cancellation of remaining options pursuant to Note 6 below.
  4. These options vested monthly starting November 17, 2022, with cancellation of remaining options pursuant to Note 6 below.
  5. These options vested monthly for 48 months following December 2, 2019.
  6. Pursuant to a Transition Agreement with the Reporting Person, all unvested options were cancelled after June 30, 2024.